Recent advances in antimalarial chemotherapy and drug resistance.
D000371:Agglutination; D000655:Amodiaquine / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000962:Antimalarials / Q000494:pharmacology*; D002738:Chloroquine / Q000494:pharmacology; D003429:Cross Reactions; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004351:Drug Resistance; D005493:Folic Acid Antagonists; D000882:Haplorhini; D006801:Humans; D008034:Lincomycin / Q000494:pharmacology; D008288:Malaria / Q000188:drug therapy*; D010860:Pigments, Biological / Q000378:metabolism; D010961:Plasmodium / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D010962:Plasmodium berghei / Q000187:drug effects / Q000378:metabolism; D010963:Plasmodium falciparum / Q000187:drug effects; D010966:Plasmodium vivax / Q000187:drug effects; D011319:Primaquine / Q000494:pharmacology; D011739:Pyrimethamine / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000494:pharmacology; D013450:Sulfones / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D010860:Pigments, Biological; D011804:Quinolines; D013449:Sulfonamides; D013450:Sulfones; D000655:Amodiaquine; D002738:Chloroquine; D011803:Quinine; D008034:Lincomycin; D011796:Quinacrine; D011319:Primaquine; D011739:Pyrimethamine